G
GRI
GRI Bio
2.100
+0.060+2.94%After Hours: 2.080 -0.020 -0.95%16:10 05/27 EDT
OPEN/PREV CLOSE2.061/2.040
TODAY RANGE2.055-2.110
VOL79.96K
MARKET CAP3.72M
52 WEEK RANGE1.970-80.36
AVG VOL (3M)80.70K
% TURNOVER4.52%
TURNOVER--
P/E (TTM)-0.0240
% RANGE2.70%
EPS(TTM)-87.4667
P/E(FORWARD)-0.4762
P/B0.3156
BVPS6.65
DIVIDEND--
P/S476.19
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.02M
SHARES OUTSTANDING1.77M
NEXT EARNINGS08/12-08/17
FREE FLOAT1.44M
LOT SIZE1
EX-DATE01/26/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·05/14 18:31
GRI Bio reports Q1 results
TipRanks·05/14 13:02
GRI Bio Highlights Promising Phase 2a IPF Data, Outlook
Benzinga·05/14 12:45
GRI Bio Q1 EPS $(1.61) Misses $(0.91) Estimate
Reuters·05/14 12:42
GRI Bio Q1 net loss narrows on lower R&D expenses
Reuters·05/14 12:35
GRI BIO Q1 NET INCOME USD -2 MILLION
TipRanks·05/14 10:40
Analysts’ Top Healthcare Picks: GRI Bio (GRI), Ovid Therapeutics (OVID)
TipRanks·04/08 13:21
GRI Bio receives UAE patent allowance for inflammatory disease treatments
Benzinga·04/07 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Dow Jones·03/11 12:52
GRI Bio Price Target Cut to $40.00/Share From $1008.00 by Ascendiant Capital
Dow Jones·03/11 12:52
GRI Bio Is Maintained at Buy by Ascendiant Capital
Same Industry
Name/Symbol
Change%
Price